EUVIMEDEUVIMED entdecken
Crossref

The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study

Sabrina Cenni, Marianna Casertano, Marco Trani, Daniela Pacella, Massimo Martinelli, Annamaria Staiano, Erasmo Miele, Caterina Strisciuglio

European Journal of Pediatrics · 2023

DOI: 10.1007/s00431-022-04771-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pediatrics, 2023. Verfasst von Sabrina Cenni und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease, Feces, S100A12 Protein. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Calgranulin-C (S100A12) and zonulin are considered markers of intestinal inflammation. Our aim was to evaluate fecal S100A12 (f-S100A12) and fecal zonulin (f-zonulin) in children with inflammatory bowel disease (IBD), compared to fecal calprotectin (FC) and serum inflammatory markers. We enrolled children with a previous diagnosis of Crohn's disease (CD) and ulcerative colitis (UC). F-S100A12, f-zonulin, and FC were determined by enzyme-linked immunosorbent assay (ELISA). Endoscopic examination was considered in the patients who underwent ileocolonoscopy within 2 weeks from the enrollment. One hundred seventeen children, 39.3% with CD and 60.7% with UC were enrolled. In both CD and UC, there was a significant direct correlation between FC and f-S100A12 levels. In children with CD and UC, both FC and f-S100A12 correlated with markers of serum inflammation. We found difference in FC and f-S100A12 levels between patients in clinical relapse and remission (FC: mean 1027 ± 818 mcg/ml vs 580 ± 695 mcg/ml respectively, p = 0.028; f-S100A12: mean 66.4 ± 48.2 mcg/ml vs 42.7 ± 40 mcg/ml, respectively p = 0.02). Moreover, we found difference in FC between children with endoscopic inflammation and remission (mean 825 ± 779 mcg/ml vs 473.3 ± 492 mcg/ml, respectively p = 0.048), as well as for f-S100A12 (53 ± 43 mcg/ml vs mean 31 ± 33 mcg/ml vs, respectively p = 0.019). No significant results were found for f-zonulin. CONCLUSION: Our data suggest that f-S100A12 and FC are both useful non-invasive biomarkers in the management of pediatric IBD in follow up and in monitoring endoscopic and clinical relapse. WHAT IS KNOWN: • Fecal calprotectin (FC), fecal S100A12 (f- S100A12), and fecal zonulin represent potential noninvasive markers of gut inflammation. • Since S100A12 is predominantly expressed by granulocytes, high levels of f-S100A12 should be more specific for inflammation than FC. WHAT IS NEW: • FC and f-S100A12 were correlated to each other and despite the lack of correlation with disease location, they were associated with endoscopic inflammation and clinical relapse in children with IBD. • No significant correlations were found between f-zonulin and the inflammatory parameters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeCrohn DiseaseFecesS100A12 ProteinHaptoglobinsHumansChildChild, PreschoolAdolescentInflammationBiomarkersEndoscopyProtein Precursors

Stichwörter der Autor:innen

Calgranulin-CFecal S100A12Fecal calprotectinFecal zonulinInflammatory bowel disease

Substanzen

S100A12 ProteinHaptoglobinsBiomarkerszonulinProtein Precursors

Autor:innen und Institutionen

  • Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Department of Woman, Child and General and Specialist Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Department of Public Health, University of Naples "Federico II", Naples, Italy.
  • Department of Translational Medical Science, Section of Pediatrics, University of Naples "Federico II", Naples, Italy.
  • Department of Woman, Child and General and Specialist Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy. caterina.strisciuglio@unicampania.it.

Zitieren

APA

Cenni, S., Casertano, M., Trani, M., Pacella, D., Martinelli, M., Staiano, A., Miele, E., & Strisciuglio, C. (2023). The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study. European Journal of Pediatrics. https://doi.org/10.1007/s00431-022-04771-7

Vancouver

Cenni S, Casertano M, Trani M, Pacella D, Martinelli M, Staiano A, et al. The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study. European Journal of Pediatrics. 2023. doi:10.1007/s00431-022-04771-7

BibTeX
@article{Cenni2023,
  author = {Cenni, Sabrina and Casertano, Marianna and Trani, Marco and Pacella, Daniela and Martinelli, Massimo and Staiano, Annamaria and Miele, Erasmo and Strisciuglio, Caterina},
  title = {The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study},
  journal = {European Journal of Pediatrics},
  year = {2023},
  doi = {10.1007/s00431-022-04771-7}
}
Kostenlos starten →